Julia Robinson

Clinical and Science Editor

julia.robinson@rpharms.com

Julia Robinson is our Senior Data Journalist

First monoclonal antibody treatment approved for prevention of COVID-19

Evusheld is the first monoclonal antibody treatment to be approved as a 'pre-exposure prophylaxis' treatment.…

Resistant mutation found in some COVID-19 patients treated with sotrovimab

The stewardship of monoclonal antibodies is vital to prevent transmission of potentially resistant COVID-19 variants, the researchers said.…

Antiseptic as effective as antibiotics in preventing recurrent UTIs, study results suggest

There was just a small numerical difference in urinary tract infection incidence between the daily antibiotic and methenamine hippurate groups.…

Monoclonal antibody 75% effective in infants against respiratory viral infection

Nirsevimab could become the first immunisation against respiratory syncytial virus for all infants.…

Tase Oputu and Lola Dabiri: ‘We are the first, but we don’t want to be the last’

We talk to the only black pharmacists currently on the Royal Pharmaceutical Society Boards about how, and why, pharmacy must change.…

Arthritis drug may reduce mortality in hospitalised COVID-19 patients

Data from more than 8,000 hospitalised patients with severe COVID-19 show that baricitinib, given in addition to usual care, reduced the risk of invasive mechanical ventilation or death.…

NHS yet to introduce plans for zero emission ambulances despite COP26 pledge

Exclusive: The only fully electric ambulance has been used by the West Midlands Ambulance Service since October 2020.…

How will the NHS get to ‘net zero’?

Six ways the NHS is planning to reduce its carbon emissions, with analysis of draft green plans from NHS trusts.…

NHS Scotland tenders for £66m pharmacogenomics decision support service

Exclusive: The service will aim to use genomic data to improve the management of polypharmacy in primary and secondary care.…

Millions of patients with rare diseases to benefit from faster treatment access

NHS England and NHS Improvement have committed to several actions to support faster access to medicines for people with rare diseases and conditions.…